Lambert-Eaton News Forums › Forums › In the News › Firdapse Oral Therapy Expected to Become LEMS’ Treatment of Choice, Review Says

  • In the News

    Firdapse Oral Therapy Expected to Become LEMS’ Treatment of Choice, Review Says

    Posted by Forum Moderator on January 4, 2020 at 12:59 pm

    Scientists believe Firdapse (amifampridine phosphate) will soon become first-line management therapy for Lambert-Eaton myasthenic syndrome. Read more here.

    What do you think of this prediction?

    Forum Moderator replied 4 years, 4 months ago 0 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .